Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

An Evidence-based Approach to Stroke Unit Development in Zambia
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
5-013

Stroke units are the global standard for stroke care and improve outcomes independent of thrombolysis and thrombectomy.  However, they are largely absent in many resource-limited settings, especially in sub-Saharan Africa.  Before October 2023, Zambia had no stroke units.

Describe an evidence-based approach to locally contextualized guideline adaptation for stroke unit development in Zambia.

Because directly translating stroke clinical practice guidelines (CPGs) from high-resourced settings to Zambia would be impractical, we undertook a three-step systematic approach to adapt American Stroke Association (ASA) CPGs on ischemic and hemorrhagic stroke care for stroke unit development in Zambia.

First, we conducted a 300-person prospective observational cohort study of consecutive adults with stroke admitted to the University Teaching Hospital in Lusaka in order to identify areas of focus for a future stroke unit.  This study revealed high rates of urinary catheterization (47% of participants), low rates of mobilization (19% of participants were mobilized on any day during their hospitalization), insufficient rates of neuroimaging (20% of participants without neuroimaging), and high mortality (21%).  Second, these data were used to provide context for a multi-disciplinary stakeholder meeting in which the Adopt-Contextualize-Adapt approach was used to categorize ASA CPGs into those that could be directly translated to the Zambian setting, those requiring adaptation, and those that could not be easily implemented/adapted with current resources.  Discipline-specific focus groups were then used to identify implementation priorities and additional resources (training, personnel and physical resources) that would be required for successful adaptation.  Finally, results from focus groups were used to inform the development of locally contextualized Zambian CPGs and final protocols for Zambia’s first stroke unit.

Zambia’s first stroke unit opened in October 2023.  Next steps include repeating the observational cohort study in the post-implementation period to evaluate CPG uptake and impact on outcomes.

Authors/Disclosures
Mashina Chomba, MBChB (University of Zambia)
PRESENTER
Dr. Chomba has nothing to disclose.
Deanna Saylor, MD, MHS (Johns Hopkins Hospital) The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from National Multiple Sclerosis Society. The institution of Dr. Saylor has received research support from American Academy of Neurology. The institution of Dr. Saylor has received research support from United States Department of State. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Sarah Braun (University Teaching Hospital, Lusaka, Zambia) No disclosure on file
Gabriel Sneh, MD (Johns Hopkins) Dr. Sneh has nothing to disclose.
Michael Kinkata No disclosure on file
Nagapranati Nanduri No disclosure on file
Phoebe Chen Ms. Chen has nothing to disclose.
Michael Kinkata No disclosure on file
Melody T. Asukile, MBBS (University Teaching Hospital) Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Meron Gebrewold, MD (Addis Ababa University) Dr. Gebrewold has nothing to disclose.
Lorraine Chishimba, MBChB, MMED (University Teaching Hospital) Dr. Chishimba has nothing to disclose.
Alexandra Peloso, MD Dr. Peloso has nothing to disclose.
Stanley Zimba, MBBS (University Teaching Hospital) Dr. Zimba has nothing to disclose.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN (University of Rochester/CHET) An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Izukanje Sikazwe No disclosure on file
Peter Winch (Johns Hopkins University) No disclosure on file
Stefan Baral No disclosure on file
Rebecca F. Gottesman, MD (Johns Hopkins University) Dr. Gottesman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Gottesman has received research support from NIH.
Victor C. Urrutia, MD (Johns Hopkins University School of Medicine) Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Director of CME course with PeerView.